Skip to main content
. Author manuscript; available in PMC: 2007 Sep 12.
Published in final edited form as: Urol Oncol. 2006;24(5):442–447. doi: 10.1016/j.urolonc.2005.08.011

Fig. 3.

Fig. 3

Monoclonal antibody blockade of CTLA-4 allows CD28 to interact with its B7 family counter-receptor, thus stimulating a tumor specific T-cell response. (Color version of figure is available online.)

HHS Vulnerability Disclosure